Galaxy Diagnostics, Inc. — Form D/A

Galaxy Diagnostics, Inc. of Durham, NC, a company, filed a Form D amendment with the SEC on 2024-07-31. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Christopher KellyDirectorNEW YORK, NY
Christopher KellyExecutive OfficerNEW YORK, NY
Edward Jefferson BreitschwerdtDirectorResearch Triangle Park, NC
Amanda Jefferson ElamDirectorResearch Triangle Park, NC
Amanda Jefferson ElamExecutive OfficerResearch Triangle Park, NC
Joel Jefferson KimbroughDirectorResearch Triangle Park, NC
Richard Jefferson WestDirectorResearch Triangle Park, NC
Nicole BellDirectorDurham, NC
Nicole BellExecutive OfficerDurham, NC
Nicole BellRelated PersonDurham, NC
B. Jefferson ClarkDirectorDurham, NC
B. Jefferson ClarkExecutive OfficerDurham, NC
B. Jefferson ClarkRelated PersonDurham, NC
Richard WestRelated Personnew york, NY
Ricardo MaggiDirectorResearch Triangle Park, NC
Ricardo MaggiExecutive OfficerResearch Triangle Park, NC
Edward BreitschwerdtDirectorDurham, NC
Edward BreitschwerdtExecutive OfficerDurham, NC
Edward BreitschwerdtPromoterDurham, NC
Edward BreitschwerdtRelated PersonDurham, NC
Amanda ElamDirectorDurham, NC
Amanda ElamExecutive OfficerDurham, NC
Amanda ElamPromoterDurham, NC
Amanda ElamRelated PersonDurham, NC
JOEL KIMBROUGHRelated PersonDurham, NC

Other filings by this issuer (5)

FiledFormOfferingSold
2026-06-03D$5.7M$3.0M
2025-04-22D$11.2M$4.1M
2024-07-10D$2.0M$825K
2014-08-15D$1.0M$551K
2009-05-12D$100K$40K

More